Background
Considerable heterogeneity has been observed in the selection and reporting of disease-specific pediatric outcome measures in randomized controlled trials (RCTs) [1] . This makes interpretation of results and comparison across trials challenging [2] . Outcome measures in pediatric anaphylaxis trials have never previously been systematically assessed [3] . This systematic review (SR) will identify and assess outcome measures used in RCTs of anaphylaxis treatment in children. As a secondary objective, this SR will assess the evidence for current treatment modalities for anaphylaxis in the pediatric population.
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